Role of fat mass and adipokines in chronic kidney disease

被引:54
作者
Axelsson, Jonas [1 ]
Stenvinkel, Peter [1 ]
机构
[1] Karolinska Inst, Dept Clin Sci Intervent & Technol, Stockholm, Sweden
关键词
cardiovascular disease; chronic kidney disease; fat tissue; insulin resistance;
D O I
10.1097/MNH.0b013e3282f2905f
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Purpose of review As traditional risk factors cannot alone explain the high prevalence and incidence of cardiovascular disease in chronic kidney disease, the complex of insulin resistance, oxidative stress, and endothelial dysfunction has increasingly been studied as an important non-traditional risk factor. Recent studies show that the adipose tissue is a complex organ with pleiotropic functions far beyond the mere storage of energy. Fat tissue secretes a number of adipokines including leptin and adiponectin, as well as cytokines, such as resistin, visfatin, tumor-necrosis factor-a and interleukin-6. Recent findings Adipokine serum levels are markedly elevated in chronic kidney disease, likely due to a decreased renal excretion. Evidence suggests that these pluripotent signaling molecules may have multiple effects modulating insulin signaling, endothelial health and vascular outcome. Summary Fat tissue is a storage depot for energy and a source of circulating signaling molecules. It plays an important role in the catabolic uremic milieu, and has been linked to systemic inflammation and uremic anorexia. Further research is needed to investigate the complex interactions between adipokine signaling networks and its effects on vascular health and outcome in chronic kidney disease.
引用
收藏
页码:25 / 31
页数:7
相关论文
共 70 条
  • [1] Sympathetic neural activation in visceral obesity
    Alvarez, GE
    Beske, SD
    Ballard, TP
    Davy, KP
    [J]. CIRCULATION, 2002, 106 (20) : 2533 - 2536
  • [2] Subcutaneous obesity is not associated with sympathetic neural activation
    Alvarez, GE
    Ballard, TP
    Beske, SD
    Davy, KP
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 2004, 287 (01): : H414 - H418
  • [3] Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity
    Arita, Y
    Kihara, S
    Ouchi, N
    Takahashi, M
    Maeda, K
    Miyagawa, J
    Hotta, K
    Shimomura, I
    Nakamura, T
    Miyaoka, K
    Kuriyama, H
    Nishida, M
    Yamashita, S
    Okubo, K
    Matsubara, K
    Muraguchi, M
    Ohmoto, Y
    Funahashi, T
    Matsuzawa, Y
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1999, 257 (01) : 79 - 83
  • [4] Truncal fat mass as a contributor to inflammation in end-stage renal disease
    Axelsson, J
    Qureshi, AR
    Suliman, ME
    Honda, H
    Pecoits-Filho, R
    Heimbürger, O
    Lindholm, B
    Cederholm, T
    Stenvinkel, P
    [J]. AMERICAN JOURNAL OF CLINICAL NUTRITION, 2004, 80 (05) : 1222 - 1229
  • [5] Body fat mass and serum leptin levels influence epoetin sensitivity in patients with ESRD
    Axelsson, J
    Qureshi, AR
    Heimbürger, O
    Lindholm, B
    Stenvinkel, P
    Bárány, P
    [J]. AMERICAN JOURNAL OF KIDNEY DISEASES, 2005, 46 (04) : 628 - 634
  • [6] Elevated resistin levels in chronic kidney disease are associated with decreased glomerular filtration rate and inflammation, but not with insulin resistance
    Axelsson, J
    Bergsten, A
    Qureshi, AR
    Heimbürger, O
    Bárány, P
    Lönnqvist, FL
    Lindholm, B
    Nordfors, L
    Alvestrand, A
    Stenvinkel, P
    [J]. KIDNEY INTERNATIONAL, 2006, 69 (03) : 596 - 604
  • [7] Changes in fat mass correlate with changes in soluble sCD163, a marker of mature macrophages, in patients with CKD
    Axelsson, Jonas
    Moller, Holger Jon
    Witasp, Anna
    Qureshi, Abdul Rashid
    Carrero, Juan Jesus
    Heimburger, Olof
    Barany, Peter
    Alvestrand, Anders
    Lindholm, Bengt
    Moestrup, Soren K.
    Stenvinkel, Peter
    [J]. AMERICAN JOURNAL OF KIDNEY DISEASES, 2006, 48 (06) : 916 - 925
  • [8] Circulating levels of Visfatin/Pre-B-Cell colony-enhancing factor 1 in relation to genotype,GFR, body composition, and survival in patients with CKD
    Axelsson, Jonas
    Witasp, Anna
    Carrero, Juan Jesus
    Qureshi, Abdul R.
    Suliman, Mohamed E.
    Heimbuerger, Olof
    Barany, Peter
    Lindholm, Bengt
    Alvestrand, Anders
    Schalling, Martin
    Nordfors, Louise
    Stenvinkel, Peter
    [J]. AMERICAN JOURNAL OF KIDNEY DISEASES, 2007, 49 (02) : 237 - 244
  • [9] Effects of body size and body composition on survival in hemodialysis patients
    Beddhu, S
    Pappas, LM
    Ramkumar, N
    Samore, M
    [J]. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2003, 14 (09): : 2366 - 2372
  • [10] Associations of metabolic syndrome with inflammation in CKD: Results from the Third National Health and Nutrition Examination Survey (NHANES III)
    Beddhu, S
    Kimmel, PL
    Ramkumar, N
    Cheung, AK
    [J]. AMERICAN JOURNAL OF KIDNEY DISEASES, 2005, 46 (04) : 577 - 586